Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration
Author:
Funder
Novartis Pharmaceuticals Corporation
Publisher
Elsevier BV
Subject
Ophthalmology
Reference51 articles.
1. Age-related macular degeneration: new paradigms for treatment and management of AMD;Hernández-Zimbrón;Oxid Med Cell Longev,2018
2. Safety and efficacy of anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration: a report by the American Academy of Ophthalmology;Bakri;Ophthalmology,2019
3. Strengthening standards, transparency, and collaboration to support medicine evaluation: ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP);Kurz;Pharmacoepidemiol Drug Saf,2018
4. A review of uses of health care utilization databases for epidemiologic research on therapeutics;Schneeweiss;J Clin Epidemiol,2005
5. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results;Schneeweiss;Med Care,2007
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining;Experimental Biology and Medicine;2023-05
2. Associations between systemic medications and development of wet age‐related macular degeneration;Acta Ophthalmologica;2021-11-14
3. SYSTEMIC MEDICATION USE AND THE INCIDENCE AND GROWTH OF GEOGRAPHIC ATROPHY IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS;Retina;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3